MediPress Health-Limited Partnership
MediPress Health-Limited Partnership, is a research and development life science partnership and venture capital firm specializing in seed/startups investments. The firm seeks to invest in medical research and development companies. Its portfolio companies engage in the treatment of cancer with proton radiation therapy; and the development of non-surgical vaginal solutions for women with various … Read more
MediPress Health-Limited Partnership (MPRS) - Net Assets
Latest net assets as of : ILA- ILA
Based on the latest financial reports, MediPress Health-Limited Partnership (MPRS) has net assets worth ILA- ILA as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA-) and total liabilities (ILA-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ILA- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
MediPress Health-Limited Partnership - Net Assets Trend (None–None)
This chart illustrates how MediPress Health-Limited Partnership's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for MediPress Health-Limited Partnership (None–None)
The table below shows the annual net assets of MediPress Health-Limited Partnership from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to MediPress Health-Limited Partnership's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
MediPress Health-Limited Partnership Competitors by Market Cap
The table below lists competitors of MediPress Health-Limited Partnership ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
HDFC Bank of Sri Lanka
CM:HDFCN0000
|
$1.36K |
|
AEGIRBIO AB
F:52Q
|
$1.36K |
|
China Harmony Auto Holding Ltd
STU:HA5
|
$1.36K |
|
Globa Terra Acquisition Corporation Warrants
NASDAQ:GTERW
|
$1.36K |
|
SSNBF
OTCGREY:SSNBF
|
$1.35K |
|
CHINA TRAVEL INTL
BE:CTI
|
$1.35K |
|
BIOALLIANCE PHARMA
MU:C4X
|
$1.35K |
|
Emco Industries Ltd
KAR:EMCO
|
$1.35K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in MediPress Health-Limited Partnership's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares MediPress Health-Limited Partnership's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently MediPress Health-Limited Partnership utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares MediPress Health-Limited Partnership's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $45,679,200
- Average return on equity (ROE) among peers: -5.42%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| MediPress Health-Limited Partnership (MPRS) | ILA- | N/A | N/A | $1.35K |
| Allmed Solutions Ltd (ALMD) | $45.13 Million | -46.38% | 0.26x | $96.61K |
| Erika Carmel Ltd (BCUR) | $8.97 Million | 138.94% | 4.32x | $46.92K |
| Bio-View Ltd (BIOV) | $23.45 Million | -5.34% | 0.48x | $54.59K |
| Erech Finance Cahalacha Ltd (EFNC) | $-63.00K | 0.00% | 0.00x | $19.28K |
| Endymed (ENDY) | $14.70 Million | 5.78% | 0.34x | $118.10K |
| Epitomee Medical Ltd (EPIT) | $34.80 Million | -16.33% | 0.16x | $567.43K |
| Human Xtensions Ltd (HUMX) | $61.78 Million | -72.18% | 0.17x | $21.16K |
| Ilex Medical (ILX) | $109.44 Million | 17.00% | 0.55x | $2.01 Million |
| Pulsenmore Ltd (PULS) | $132.23 Million | -44.29% | 0.36x | $321.83K |
| Sofwave Medical Ltd (SOFW) | $26.34 Million | -31.42% | 0.65x | $3.18 Million |